Language differences in qualitative research: is meaning lost in translation?

This article discusses challenges of language differences in qualitative research, when participants and the main researcher have the same non-English native language and the non-English data lead to an English publication. Challenges of translation are discussed from the perspective that interpretation of meaning is the core of qualitative research. As translation is also an interpretive act, meaning may get lost in the translation process. Recommendations are suggested, aiming to contribute to the best possible representation and understanding of the interpreted experiences of the participants and thereby to the validity of qualitative research.     

VENOUS NEEDLE DISLODGEMENT: THE PITFALLS OF VENOUS PRESSURE MEASUREMENT AND POSSIBLE ALTERNATIVES,A REVIEW

The historical development of the use of pressure sensors as protective system against blood loss to the environment is reviewed. In spite of early warnings about the deficiency of such sensors, the venous pressure sensor is still formally accepted as protective system against blood loss to the environment in case of leaks or needle dislodgement. The early warnings were corroborated by publications and accident reports. Several alternative methods have been developed or described in the literature recently. These methods are critically reviewed. The conclusion is that external monitors are currently the only available alternatives, although long‐time clinical experience is missing. Methods employing sensors integrated into dialysis machines have been described but it is unlikely that any of these methods will become available in the immediate future.     

A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency

Background  

A potential role for muscle in glucose homeostasis was recently suggested based on characterization of extrahepatic and extrarenal glucose-6-phosphatase (glucose-6-phosphatase-β). To study the role of extrahepatic tissue in glucose homeostasis during fasting glucose kinetics were studied in two patients with a deficient hepatic and renal glycogenolysis and/or gluconeogenesis.     

In vivo specific tension of the human quadriceps femoris muscle

It is not known to what extent the inter-individual variation in human muscle strength is explicable by differences in specific tension. To investigate this, a comprehensive approach was used to determine in vivo specific tension of the quadriceps femoris (QF) muscle (Method 1). Since this is a protracted technique, a simpler procedure was also developed to accurately estimate QF specific tension (Method 2). Method 1 comprised calculating patellar tendon force (F _t) in 27 young, untrained males, by correcting maximum voluntary contraction (MVC) for antagonist co-activation, voluntary activation and moment arm length. For each component muscle, the physiological cross-sectional area (PCSA) was calculated as volume divided by fascicle length during MVC. Dividing F _t by the sum of the four PCSAs (each multiplied by the cosine of its pennation angle during MVC) provided QF specific tension. Method 2 was a simplification of Method 1, where QF specific tension was estimated from a single anatomical CSA and vastus lateralis muscle geometry. Using Method 1, the variability in MVC (18%) and specific tension (16%) was similar. Specific tension from Method 1 (30 ± 5 N cm⁻²) was similar to and correlated with that of Method 2 (29 ± 5 N cm⁻²; R ² = 0.67; P < 0.05). In conclusion, most of the inter-individual variability in MVC torque remains largely unexplained. Furthermore, a simple method of estimating QF specific tension provided similar values to the comprehensive approach, thereby enabling accurate estimations of QF specific tension where time and resources are limited.     

Comprehensive genetic and functional characterization of IPH‐926: a novel CDH1‐null tumour cell line from human lobular breast cancer

Infiltrating lobular breast cancer (ILBC) is a clinically and biologically distinct tumour entity defined by a characteristic linear cord invasion pattern and inactivation of the CDH1 tumour suppressor gene encoding for E‐cadherin. ILBCs also lack β‐catenin expression and show aberrant cytoplasmic localization of the E‐cadherin binding protein p120‐catenin. The lack of a well‐characterized ILBC cell line has hampered the functional characterization of ILBC cells in vitro. We report the establishment of a permanent ILBC cell line, named IPH‐926, which was derived from a patient with metastatic ILBC. The DNA fingerprint of IPH‐926 verified genetic identity with the patient and had no match among the human cell line collections of several international biological resource banks. IPH‐926 expressed various epithelial cell markers but lacked expression of E‐cadherin due to a previously unreported, homozygous CDH1 241ins4 frameshift mutation. Detection of the same CDH1 241ins4 mutation in archival tumour tissue of the corresponding primary ILBC proved the clonal origin of IPH‐926 from this particular tumour. IPH‐926 also lacked β‐catenin expression and showed aberrant cytoplasmic localization of p120‐catenin. Array‐CGH analysis of IPH‐926 revealed a profile of genomic imbalances that included many distinct alterations previously observed in primary ILBCs. Spectral karyotyping of IPH‐926 showed a hyperdiploid chromosome complement and numerous clonal, structural aberrations. IPH‐926 cells were anti‐cancer drug‐resistant, clonogenic in soft agar, and tumourigenic in SCID mice. In xenograft tumours, IPH‐926 cells recapitulated the linear cord invasion pattern that defines ILBCs. In summary, IPH‐926 significantly extends the biological spectrum of the established breast cancer cell lines and will facilitate functional analyses of genuine human ILBC cells in vitro and in vivo. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.